Literature DB >> 15027004

Valency of antibody binding to virions and its determination by surface plasmon resonance.

Nigel J Dimmock1, Sam A Hardy.   

Abstract

All IgGs are homobivalent, but their ability to bind bivalently to the surface of a virus particle depends mainly on a favourable spacing of cognate epitopes and the angle that the FAb arm makes with the virus surface. If the angle of binding forces the second FAb arm to point into solution, monovalent binding is inevitable. This IgG will have the same affinity as its FAb, will be less stably bound than if it were bound bivalently, cannot cross-link epitopes on the surface of a virion, and cannot neutralise by cross-linking surface proteins. However, at moderate IgG concentrations, monovalently bound IgG can reduce infectivity by aggregating virions, a phenomenon that cannot occur with IgG bound bivalently. This review describes how surface plasmon resonance can be used to determine the valency of IgG binding to enveloped and non-enveloped virus particles, and discusses the implications of this new methodology. Copyright 2004 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15027004     DOI: 10.1002/rmv.419

Source DB:  PubMed          Journal:  Rev Med Virol        ISSN: 1052-9276            Impact factor:   6.989


  6 in total

1.  Neutralization efficiency is greatly enhanced by bivalent binding of an antibody to epitopes in the V4 region and the membrane-proximal external region within one trimer of human immunodeficiency virus type 1 glycoproteins.

Authors:  Pengcheng Wang; Xinzhen Yang
Journal:  J Virol       Date:  2010-05-12       Impact factor: 5.103

2.  Molecular basis for the high degree of antigenic cross-reactivity between hepatitis B virus capsids (HBcAg) and dimeric capsid-related protein (HBeAg): insights into the enigmatic nature of the e-antigen.

Authors:  Norman R Watts; Joe G Vethanayagam; R Bridget Ferns; Richard S Tedder; Audray Harris; Stephen J Stahl; Alasdair C Steven; Paul T Wingfield
Journal:  J Mol Biol       Date:  2010-03-20       Impact factor: 5.469

3.  Dissection of Epitope-Specific Mechanisms of Neutralization of Influenza Virus by Intact IgG and Fab Fragments.

Authors:  James A Williams; Long Gui; Nancy Hom; Alexander Mileant; Kelly K Lee
Journal:  J Virol       Date:  2018-02-26       Impact factor: 5.103

4.  Conformation-controlled binding kinetics of antibodies.

Authors:  Marta Galanti; Duccio Fanelli; Francesco Piazza
Journal:  Sci Rep       Date:  2016-01-12       Impact factor: 4.379

5.  Coming together at the hinges: Therapeutic prospects of IgG3.

Authors:  Thach H Chu; Edward F Patz; Margaret E Ackerman
Journal:  MAbs       Date:  2021 Jan-Dec       Impact factor: 5.857

6.  Antibody bivalency improves antiviral efficacy by inhibiting virion release independently of Fc gamma receptors.

Authors:  Mehmet Sahin; Melissa M Remy; Benedict Fallet; Rami Sommerstein; Marianna Florova; Anna Langner; Katja Klausz; Tobias Straub; Mario Kreutzfeldt; Ingrid Wagner; Cinzia T Schmidt; Pauline Malinge; Giovanni Magistrelli; Shozo Izui; Hanspeter Pircher; J Sjef Verbeek; Doron Merkler; Matthias Peipp; Daniel D Pinschewer
Journal:  Cell Rep       Date:  2022-02-01       Impact factor: 9.423

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.